APA (7th ed.) Citation

Salukhov, V. V., Shipilova, D. A., & Minakov, A. A. Long-term results of transferring the patient from therapy with glucagon-like peptide-1 receptor agonists in combination with metformin to a dipeptidyl peptidase-4 inhibitor in combination with pioglitazone and inhibitor of type 2 sodium-glucose cotransporter in type 2 diabetes. Endocrinology Research Centre.

Chicago Style (17th ed.) Citation

Salukhov, V. V., D. A. Shipilova, and A. A. Minakov. Long-term Results of Transferring the Patient from Therapy with Glucagon-like Peptide-1 Receptor Agonists in Combination with Metformin to a Dipeptidyl Peptidase-4 Inhibitor in Combination with Pioglitazone and Inhibitor of Type 2 Sodium-glucose Cotransporter in Type 2 Diabetes. Endocrinology Research Centre.

MLA (9th ed.) Citation

Salukhov, V. V., et al. Long-term Results of Transferring the Patient from Therapy with Glucagon-like Peptide-1 Receptor Agonists in Combination with Metformin to a Dipeptidyl Peptidase-4 Inhibitor in Combination with Pioglitazone and Inhibitor of Type 2 Sodium-glucose Cotransporter in Type 2 Diabetes. Endocrinology Research Centre.